Electronic Common Technical Document (eCTD) submission platform supporting first-time-right regulatory submissions to US FDA, EMA, Health Canada, and 12+ global health authorities.
pharmaREADY eCTD is a multi-tenant SaaS platform for electronic regulatory submissions compliant with ICH and regional guidelines. Managed 250,000+ submissions to date across global regulatory health authorities including US FDA, EMA, and Health Canada.
Platform features drag-and-drop assembly, template-based workflow, automated file naming per ICH and regional guidelines, multi-stage approval cycles, and a validation engine. Supports pharmaceuticals, biologics/biosimilars, medical devices, generic drugs, and animal health products.
Implementation typically less than 1 week for SaaS deployment, which minimizes startup costs with no customer hardware or software required. Can integrate with pharmaREADY DMS, SPL, and TRMS modules for submission lifecycle management.
Key capabilities include auto-correction of PDF documents, in-place PDF editing, auto conversion to PDF, and simultaneous submissions to multiple agencies. Role-based authoring and electronic content assembly enable first-time-right submissions.
Pharmaceutical Edition
pharmaREADY eCTD is part of the pharmaREADY platform suite designed exclusively for pharmaceutical and biopharmaceutical regulatory submissions. The platform serves 200+ global biopharma companies with integrated modules for document management, submission publishing, labeling, and tracking.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
Multi-tenant SaaS platform with web-based interface accessible via standard web browsers. Available both as hosted SaaS solution and on-site deployment. SaaS deployment minimizes startup costs with no customer hardware or software required.
Platform is fully integrated and web-based, enabling integration with other pharmaREADY modules including Document Management System (DMS), Structured Product Labeling (SPL), and Tracking and Regulatory Management System (TRMS). Integration between modules enables submission workflow completion in 40% less time according to vendor claims. Cloud hosting eliminates IT infrastructure requirements for customers choosing SaaS deployment.
Subscription-based SaaS pricing model. Vendor claims "Lowest Total Cost of Ownership in the Industry". Specific pricing not publicly disclosed.
SaaS deployment minimizes upfront costs with no customer hardware or software investments required. On-site deployment option available with different pricing structure. Vendor claims integrated module usage enables 40% faster submission completion. Free trial availability is undisclosed.
SaaS implementation typically less than 1 week. Multi-tenant SaaS architecture minimizes implementation complexity and startup costs as no customer hardware or software is required. Platform requires minimal IT involvement.
On-site deployment option available for customers requiring on-premise hosting. Implementation includes configuration of template-based workflows, role-based access controls, and approval cycles. Integration with existing pharmaREADY modules (DMS, SPL, TRMS) available for customers using the broader pharmaREADY platform suite. Platform serves 200+ global biopharma companies with 250,000+ submissions managed to date.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Platform managed 250,000+ submissions to date across 200+ global biopharma companies. Key strengths include first-time-right submission capability, a validation engine, and an implementation timeline of less than 1 week for SaaS. Integrated modules enable 40% faster submission completion according to vendor claims. Multi-tenant SaaS architecture minimizes IT infrastructure requirements.
Limitations & Open Questions
No third-party reviews on major platforms (G2, Capterra, Gartner Peer Insights). Specific customer names not disclosed publicly. Pricing not transparent - requires sales contact for quotes. Total cost of ownership claims not independently verified. Platform primarily focused on regulatory submission - requires additional pharmaREADY modules for broader regulatory lifecycle management.
Help the community
Share your experience with pharmaREADY eCTD anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackJump to section